Research location

Valladolid

Spain

Published trials172

Site observations180

Linked trials published172

Page2 / 4

Research activity in Valladolid

Spain

CureCurrent currently publishes aggregate city-level research activity for this location: 172 trials and 180 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Valladolid

172 linked trials · page 2 of 4

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 1 site observation

ACTIVE_NOT_RECRUITING

DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:NCT04884139 · 2021-07-14 · 1 site observation

Reading Problems Associated With Central Nervous System (CNS) Pathologies.NCT04937725 · 2021-06-01 · 1 site observation

Tivanisiran for Dry Eye in Subjects With Sjögren's SyndromeNCT04819269 · 2021-05-25 · 1 site observation

Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc ImagesNCT04972695 · 2021-05-07 · 1 site observation

Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsNCT05009030 · 2021-05-06 · 1 site observation

Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb IschemiaNCT04466007 · 2021-01-11 · 1 site observation

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung CancerNCT04712903 · 2020-12-16 · 1 site observation

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated PatientsNCT04512430 · 2020-12-02 · 1 site observation

Salt Intake, Microbiota, Immune Response and Endothelial Function in HypertensionNCT04648592 · 2020-12-01 · 1 site observation

Sacituzumab Govitecan in Primary HER2-negative Breast CancerNCT04595565 · 2020-10-28 · 1 site observation

ACTIVE_NOT_RECRUITING

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)NCT04611152 · 2020-09-30 · 1 site observation

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic TreatmentNCT04421456 · 2020-08-18 · 1 site observation

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaNCT04531982 · 2020-08-05 · 1 site observation

Personalized Therapy Study - HFRS (TriageHF) Post Approval StudyNCT04489225 · 2020-08-01 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study to Evaluate THR-149 Treatment for Diabetic Macular OedemaNCT04527107 · 2020-07-31 · 1 site observation

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)NCT04442503 · 2020-06-08 · 1 site observation

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic RetinopathyNCT04265261 · 2020-06-05 · 1 site observation

Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.NCT04285866 · 2020-05-21 · 1 site observation

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)NCT04344002 · 2020-04-21 · 1 site observation

Study of the Immunity of Patients With Lung Cancer and COVID-19 InfectionNCT04407143 · 2020-04-15 · 1 site observation

Vortioxetine in Patients With Depression and Early DementiaNCT04294654 · 2020-02-28 · 2 site observations

Global Utilization And Registry Database for Improved heArt preservatioNNCT04141605 · 2020-02-14 · 1 site observation

ENROLLING_BY_INVITATION

A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderNCT04041284 · 2019-09-13 · 1 site observation

Safety of Bosentan in Type II Diabetic PatientsNCT04068272 · 2019-09-07 · 1 site observation

Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerNCT03820830 · 2019-08-27 · 1 site observation

ACTIVE_NOT_RECRUITING

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeNCT04067999 · 2019-08-05 · 1 site observation

A Real-world Study of Imraldi® UseNCT04089514 · 2019-06-30 · 1 site observation

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positiveNCT03790397 · 2019-02-26 · 1 site observation

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeNCT03782207 · 2019-02-07 · 1 site observation

Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM AlgorithmNCT03961399 · 2018-12-18 · 1 site observation

A Tube Feeding Study in Malnourished Population With DiabetesNCT03766620 · 2018-11-29 · 1 site observation

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthlyNCT03809325 · 2018-11-21 · 1 site observation

Reducing Lung CongestIon Symptoms in Advanced Heart FailureNCT03499236 · 2018-09-19 · 1 site observation

ACTIVE_NOT_RECRUITING

Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse RiskNCT03800355 · 2018-09-14 · 1 site observation

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain MetastasisNCT03526900 · 2018-07-07 · 1 site observation

PeriOperative ISchemic Evaluation-3 TrialNCT03505723 · 2018-06-27 · 1 site observation

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityNCT03552757 · 2018-06-04 · 1 site observation

Elaboration of New Generation SnacksNCT03420989 · 2018-01-18 · 1 site observation

Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular HypertensionNCT03284853 · 2017-09-05 · 1 site observation

Personalized Therapy Study - Attain Stability Quad Post-Approval StudyNCT04024943 · 2017-08-21 · 1 site observation

ACTIVE_NOT_RECRUITING

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer PatientsNCT03017313 · 2017-07-13 · 1 site observation

Attain Stability™ Quad Clinical StudyNCT03099655 · 2017-07-07 · 1 site observation

Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 DiabetesNCT03191396 · 2017-06-27 · 1 site observation

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientNCT03132493 · 2017-06-01 · 1 site observation

OTIVACTO Spain Non Interventional StudyNCT02927795 · 2017-04-26 · 2 site observations

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)NCT03057977 · 2017-03-06 · 1 site observation

Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586 · 2017-01-01 · 1 site observation

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 InfectionNCT03158077 · 2016-11-15 · 1 site observation

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)NCT02970305 · 2016-11-04 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.